Screener
Arcutis Biotherapeutics, Inc. ARQT Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $15.01M+194% | -$11.3M+54.9% | —— | $7.41M+118% | -$15.89M+69.6% | ||
| $12.76M+21.7% | $10.69M+9.3% | $10.06M+7.1% | $10.04M+2.6% | $10.49M-16.2% | ||
| $12.64M— | $2.24M+107% | —— | -$1.75M+94.9% | —— | ||
| $158K+103% | $0-100% | —— | —— | $78K— | ||
| -$15.22M-187% | -$11.33M-196% | -$34.18M-198% | -$25.25M-130% | $17.42M+128% | ||
| —— | —— | $0-100% | $0-100% | $0-100% | ||
| $1.99M+44.2% | $1.07M+170% | $3.72M— | $1.48M+275% | $1.38M-5.2% | ||
| -$641K-103% | -$8.15M+55.3% | -$4.21M+93.4% | -$25.62M-151% | $19.33M+118% | ||
| $12.48M— | $2.24M+107% | —— | -$1.75M+95.0% | —— |
FAQ
- How much cash does Arcutis Biotherapeutics, Inc. generate?
- Arcutis Biotherapeutics, Inc. (ARQT) generated -$17.3M in operating cash flow over the trailing twelve months.
- What is Arcutis Biotherapeutics, Inc.'s free cash flow?
- After $844.0K of capital expenditures, Arcutis Biotherapeutics, Inc.'s free cash flow was -$18.0M over the trailing twelve months, up 84.0% year over year.
- Where does Arcutis Biotherapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Arcutis Biotherapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
